Invention Grant
- Patent Title: Compounds which selectively modulate the CB2 receptor
-
Application No.: US12564133Application Date: 2009-09-22
-
Publication No.: US08372874B2Publication Date: 2013-02-12
- Inventor: Alessandra Bartolozzi , Eugene Richard Hickey , Doris Riether , Lifen Wu , Renee M. Zindell , Monika Ermann
- Applicant: Alessandra Bartolozzi , Eugene Richard Hickey , Doris Riether , Lifen Wu , Renee M. Zindell , Monika Ermann
- Applicant Address: DE Ingelheim am Rhein
- Assignee: Boehringer Ingelheim International GmbH
- Current Assignee: Boehringer Ingelheim International GmbH
- Current Assignee Address: DE Ingelheim am Rhein
- Agent Michael P. Morris; Anthony P. Bottino
- Main IPC: A61K31/4196
- IPC: A61K31/4196 ; A61K31/42 ; A61K31/422 ; C07D261/14 ; C07D249/14
Abstract:
Compounds of formula (I) are disclosed. Compounds according to the invention bind to and are agonists, antagonists or inverse agonists of the CB2 receptor, and are useful for treating inflammation. Those compounds which are agonists are additionally useful for treating pain.
Public/Granted literature
- US20100076029A1 Compounds Which Selectively Modulate The CB2 Receptor Public/Granted day:2010-03-25
Information query
